ArticleInternational journal of surgery case reports2025
Breast mucoepidermoid carcinoma: about a case report.
Article in International journal of surgery case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introduction and importanceBreast mucoepidermoid carcinoma (MEC) is a very rare entity and usually underdiagnosed by the pathologists. CASE PRESENTATION: 54-year-old woman with a single palpable mass on the left breast with no nipple discharge. She underwent tumoretomy. Microscopic examination revealed a well circumstanced intracystic proliferation consisted of mucoid, epidermoid and intermediate cells. The tumor cells were positive for ER, PR but negative for HER2. CLINICAL DISCUSSION: Salivary glands like neoplasms are described in the breast, and only represent 0.2 % to 0.3 % of breast carcinomas. They usually fall under the triple negative breast carcinomas. However some cases were described in the literature with a luminal A profile. The grading score used in the salivary glands based on the presence or lack thereof nuclear anaplasia, necrosis, high mitotic activity and perineural or lymphovascular invasion seems more appropriate in this rare entity.
conclusionsIt is crucial for pathologists to think of this type of Breast carcinomas, especially when there is mucoid, epidermoid and intermediate cells and it does not have to fall under triple negative breast carcinomas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.